Clinical Trials Browser

Phase 4 × Active not recruiting × Other hematologic neoplasm × Clear all

NCT02386800 2026-03-16

CINC424A2X01B Rollover Protocol

Phase 4 Active not recruiting

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

NCT04296305 2025-12-26

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain

Phase 4 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT04745910 2025-12-18

Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

Phase 4 Active not recruiting

Other hematologic neoplasm

Tumor Lysis Syndrome, Hematologic Neoplasms

NCT03023631 2025-11-18

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Phase 4 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT03229200 2025-10-30

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Phase 4 Active not recruiting

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell

NCT05144243 2025-08-12

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Phase 4 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease